To evaluate the clinical relevance of miR-103/107-induced Axin2 repression, we analyzed Axin2 and miR-103/107 expression by immunohistochemistry (IHC) and in situ hybridization (ISH), respectively, on consecutive slides derived from a cohort of CRC specimens. The gene discussed is AXIN2; the disease is colorectal carcinoma.